Evidence map›Paper›PMID 33026975›Full record

ArticleeLife2020

Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis.

Yen-Lin Huang, Ching-Yeu Liang, Danilo Ritz, Ricardo Coelho, Dedy Septiadi, Manuela Estermann, Cécile Cumin, Natalie Rimmer, Andreas Schötzau, Mónica Núñez López and 9 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Yen-Lin HuangOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.ORCID 0000-0002-3678-3815
Ching-Yeu LiangOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.ORCID 0000-0002-9027-1853
Danilo RitzProteomics core facility, Biozentrum, University of Basel, Basel, Switzerland.
Ricardo CoelhoDifferentiation and Cancer group, Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Dedy SeptiadiAdolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.
Manuela EstermannAdolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.
Cécile CuminOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Natalie RimmerOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Andreas SchötzauOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Mónica Núñez LópezOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
André FedierOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Martina KonantzStem Cells and Hematopoiesis, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0002-4319-3119
Tatjana VlajnicInstitute of Pathology, University Hospital Basel, Basel, Switzerland.
Diego CalabreseHistology Core Facility, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Claudia LengerkeStem Cells and Hematopoiesis, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Leonor DavidDifferentiation and Cancer group, Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Barbara Rothen-RutishauserAdolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.
Francis JacobOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.ORCID 0000-0002-0446-1942
Viola Heinzelmann-SchwarzOvarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
University of Basel · CHUniversity of Fribourg · CHUniversidade do Porto · PTUniversity Hospital of Basel · CH

Funding

FreeNovation FreeNovation 2016Swiss National Science Foundation Sinergia 171037University of Basel DMM2051
6 · The paper itself

Abstract

The extracellular matrix (ECM) plays critical roles in tumor progression and metastasis. However, the contribution of ECM proteins to early metastatic onset in the peritoneal cavity remains unexplored. Here, we suggest a new route of metastasis through the interaction of integrin alpha 2 (ITGA2) with collagens enriched in the tumor coinciding with poor outcome in patients with ovarian cancer. Using multiple gene-edited cell lines and patient-derived samples, we demonstrate that ITGA2 triggers cancer cell adhesion to collagen, promotes cell migration, anoikis resistance, mesothelial clearance, and peritoneal metastasis in vitro and in vivo. Mechanistically, phosphoproteomics identify an ITGA2-dependent phosphorylation of focal adhesion kinase and mitogen-activated protein kinase pathway leading to enhanced oncogenic properties. Consequently, specific inhibition of ITGA2-mediated cancer cell-collagen interaction or targeting focal adhesion signaling may present an opportunity for therapeutic intervention of metastatic spread in ovarian cancer.

Indexed as

AnimalsCarcinoma, Ovarian EpithelialCell Line, TumorCollagenFemaleIntegrin alpha2MiceNeoplasm MetastasisOmentumPeritoneumZebrafishCollagenIntegrin alpha2cancer biologyCell adhesioncell biologyCollagenfocal adhesion kinasehumanintegrin alpah 2mouseomentumPeritoneal metastasiszebrafish

Identifiers

PMID33026975
PMCPMC7541088
OpenAlexW3092230054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.